Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Markus Falk

8PUBLICATIONS

21CO-AUTHORS

Gene and molecular therapyMolecular targetsCancer genetics

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Aug 09, 2024

Intracranial response to capmatinib after progression on crizotinib in a patient with <i>MET</i> exon 14 skipping non-small cell lung cancer-a case report.

Balázs Jóri, Otto Bundschuh, Markus Falk

|Oct 27, 2023

Fluctuation of Acquired Resistance Mutations and Re-Challenge with EGFR TKI in Metastatic NSCLC: A Case Report.

Markus Falk, Stefanie Schatz, Fabian P M Reich

|Oct 27, 2023

The Combined Therapy of Cabozantinib, Crizotinib, and Osimertinib in a Lung Cancer Patient with Acquired MET Amplification and Resistance Mutations.

Balázs Jóri, Christine Vössing, Judith Pirngruber

|Jul 14, 2023

Development of the NOGGO GIS v1 Assay, a Comprehensive Hybrid-Capture-Based NGS Assay for Therapeutic Stratification of Homologous Repair Deficiency Driven Tumors and Clinical Validation.

Eva-Maria Willing, Claudia Vollbrecht, Christine Vössing

|Feb 24, 2023

Response of an HER2-Mutated NSCLC Patient to Trastuzumab Deruxtecan and Monitoring of Plasma ctDNA Levels by Liquid Biopsy.

Markus Falk, Eva Willing, Stefanie Schmidt

|Sep 22, 2022

Acquired G2032R Resistance Mutation in ROS1 to Lorlatinib Therapy Detected with Liquid Biopsy.

Balázs Jóri, Markus Falk, Iris Hövel

Pageof 2

Frequent Collaborators

4 joint publications

Stefanie Schatz

4 joint publications

Balázs Jóri

2 joint publications

Wolfgang M Brueckl

2 joint publications

Eva-Maria Willing

1 joint publications

André Fehr

1 joint publications

Reinhard E Friedrich

1 joint publications

Andreas Stang

1 joint publications

Florian Oesterling

1 joint publications

Göran Stenman

1 joint publications

Thomas Löning

Frequent Collaborators

4 joint publications

Stefanie Schatz

4 joint publications

Balázs Jóri

2 joint publications

Wolfgang M Brueckl

2 joint publications

Eva-Maria Willing

Top Related Videos

Utilizing <sup>18</sup>F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing <sup>18</sup>F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on : Jul 21, 2018

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

See more related videos

Top Related Videos

Utilizing <sup>18</sup>F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing <sup>18</sup>F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on : Jul 21, 2018

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

See more related videos